Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer.

H, Zhao; G, Yang; D, Wang; X, Yu; Y, Zhang; J, Zhu; Y, Ji; B, Zhong; W, Zhao; Z, Yang; F, Aziz

doi:10.1097/cad.0b013e32833641a7

Public

Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer.

Shared by NobleBlocks on Apr 1, 2010 • 12:00 AM UTC

Authors:

Zhao H

Yang G

Wang D

Abstract

This phase II trial was conducted to evaluate the safety and efficacy of concurrent gemcitabine and high-intensity focused ultrasound (HIFU) therapy in patients with locally advanced pancreatic cancer. Patients with localized unresectable pancreatic adenocarcinoma in the head or body of the pancreas...

Discussions